| rhBMP-2 | Recombinant human bone morphogenetic protein-2 |
| TCP | Tricalcium-phosphate |
| HA | Hydroxyapatite |
| RANKL | Receptor activator of nuclear factor kappa ligand |
| PRISMA | Preferred reporting items for systematic reviews and meta-analyses |
| TP | Transverse process |
| BV% | Bone volume percentage |
| SYRCLE | Systematic review center for laboratory animal experimentation |
| ACDF | Anterior cervical discectomy and fusion |
| PLGA | Poly(lactic-co-glycolic acid) |
| DBM | Demineralized bone matrix |
| BMSC | Bone marrow stem cell |
| ADSC | Adipose stem cell |
| PRP | Platelet-rich plasma |
| PDRN | Polydeoxyribonucleotide |
| Ti-Al-V | Titanium–aluminum–vanadium |
| CaSR | Calcium-sensing receptor |
| PCL | Polycaprolactone |
| VEGF | Vascular endothelial growth factor |